Pharmadrug Inc.
PHRX
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -154.80K | -244.80K | -288.10K | -586.90K | -9.68M |
| Total Depreciation and Amortization | 36.00K | 36.10K | 36.20K | 36.70K | 47.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 78.20K | 149.20K | 202.80K | 213.50K | 9.05M |
| Change in Net Operating Assets | -29.50K | -9.30K | -116.70K | -222.10K | -188.40K |
| Cash from Operations | -70.20K | -69.00K | -166.00K | -558.90K | -773.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 545.10K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.60K | -8.60K | -8.60K | -8.60K | -200.00 |
| Cash from Investing | -8.60K | -8.60K | -8.60K | -8.60K | 544.80K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 326.00K | 326.00K |
| Repurchase of Common Stock | -91.60K | -91.60K | -91.60K | -91.60K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.20K | 87.20K | 87.20K | 87.20K | -51.10K |
| Cash from Financing | -3.20K | -3.20K | -3.20K | 238.60K | 204.20K |
| Foreign Exchange rate Adjustments | -1.70K | -1.70K | -1.70K | -1.70K | 600.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | -83.60K | -82.40K | -179.40K | -330.50K | -24.00K |